Top Takeaways from ASCO: Neuro-oncology

Neuro-oncologists were buoyed by findings revealed within their subspecialty at ASCO 2015, with potentially practice-changing research presented in the plenary session, as well as in a clinical science symposium and an oral abstract session on central nervous system tumours. In addition to the cognitive risks of whole brain radiation, attendees learned the effects of immunotherapy in targeting brain tumours, particularly glioblastoma.